GlassScriptPhysician profile
Faith Leber
NPI 1609273994
$6,449.80
in general payments reported to CMS, 2019-2025
34 companies · $1,251 in 2025
The $1,251 reported for 2025 was more than what 90% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $979 · 2022: $1,470 · 2023: $1,549 · 2024: $1,200 · 2025: $1,251.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,000.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,105.19 | 2021-2025 | |
| Glaxosmithkline, LLC. | $635.41 | 2021-2025 | Arexvy, Bexsero, Shingrix |
| Novo Nordisk INC | $633.72 | 2022-2025 | Wegovy, Rybelsus, Ozempic |
| Astrazeneca Pharmaceuticals LP | $490.01 | 2021-2025 | Airsupra, Breztri, Farxiga |
| Genzyme Corporation | $468.45 | 2023-2024 | |
| Jazz Pharmaceuticals INC. | $311.26 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $229.07 | 2021-2024 | Xarelto |
| Pfizer INC. | $228.80 | 2021-2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $177.04 | 2022 | |
| Vapotherm INC | $161.03 | 2022-2023 | Vapotherm |
| Dexcom, INC. | $152.52 | 2023-2025 | Dexcom G7 Gss (161), Dexcom G6 Transmitter |
| Lilly USA, LLC | $148.31 | 2021-2025 | Mounjaro, Zepbound |
| Abbott Laboratories | $143.63 | 2022-2024 | Freestyle Libre 3 |
| Phathom Pharmaceuticals, INC. | $127.04 | 2025 | Voquezna |
| Exact Sciences Corporation | $125.13 | 2023-2025 | Cologuard Collection Kit |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $124.99 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $124.80 | 2025 | Zoryve |
| Biohaven Pharmaceuticals, INC. | $117.60 | 2021 | |
| Gilead Sciences, INC. | $116.15 | 2025 | Epclusa |
| Otsuka America Pharmaceutical, INC. | $90.93 | 2024 | Rexulti |
| Amgen INC. | $90.36 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $88.05 | 2023 | |
| Merck Sharp & Dohme LLC | $73.82 | 2021-2025 | Gardasil 9, Capvaxive |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $68.54 | 2021 | |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $67.26 | 2023 | |
| Biogen, INC. | $61.43 | 2024 | |
| Shield Therapeutics INC | $57.45 | 2023-2025 | Accrufer |
| Coloplast Corp | $56.33 | 2023 | Titan |
| Hologic Sales and Service, LLC | $56.08 | 2023-2024 | Aptima, Thinprep 2000 Processor |
| Novartis Pharmaceuticals Corporation | $44.39 | 2023 | |
| Sanofi Pasteur INC. | $37.10 | 2025 | |
| Eisai INC. | $17.76 | 2021 | |
| Scynexis, INC. | $13.88 | 2022 | |
| Genentech USA, INC. | $6.27 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Faith Leber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.